SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Sep-21 6:51 PM View: | Allakos Inc. (ALLK) | 28-Sep-21 | Option Exercise | 4,000 | $0.52 | $2,100.00 | 100% 0 to 4.0K | |
29-Sep-21 6:51 PM View: | Allakos Inc. (ALLK) | 28-Sep-21 | Market Option Sale | 4,000 | $108.12 | $432,480.00 | (100%) 4.0K to 0 | |
17-Mar-21 8:00 PM View: | Allakos Inc. (ALLK) | 16-Mar-21 | Option Exercise | 3,500 | $0.52 | $1,837.50 | 100% 3.5K to 7.0K | |
17-Mar-21 8:00 PM View: | Allakos Inc. (ALLK) | 16-Mar-21 | Market Option Sale | 3,500 | $121.65 | $425,775.00 | (50%) 7.0K to 3.5K | 18% |
13-Mar-18 6:11 PM View: | Oncothyreon Inc (CASC) | 09-Mar-18 | Disposition (change in control) | 13,677 | -- | -- | (100%) 13.68K to 0 | |
11-Dec-17 3:24 PM View: | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 12,500 | $1.52 | $19,000.00 | (100%) 12.5K to 0 | |
26-Sep-17 5:20 PM View: | Oncothyreon Inc (CASC) | 24-Sep-17 | Payment of Exercise | 594 | $3.94 | $2,340.36 | (4%) 14.27K to 13.68K | (156%) |
26-Sep-17 5:20 PM View: | Oncothyreon Inc (CASC) | 24-Sep-17 | Option Exercise | 2,375 | -- | -- | 20% 11.9K to 14.27K | |
27-Jun-17 5:40 PM View: | Oncothyreon Inc (CASC) | 24-Jun-17 | Payment of Exercise | 2,265 | $3.78 | $8,561.70 | (16%) 14.16K to 11.9K | (167%) |
27-Jun-17 5:40 PM View: | Oncothyreon Inc (CASC) | 24-Jun-17 | Option Exercise | 9,058 | -- | -- | 178% 5.1K to 14.16K | |
22-Jun-17 4:41 PM View: | Tranzyme, Inc. (OCRX) | 20-Jun-17 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
13-Jun-17 4:40 PM View: | Oncothyreon Inc (CASC) | 12-Jun-17 | Payment of Exercise | 537 | $3.34 | $1,793.58 | (10%) 5.64K to 5.1K | (202%) |
13-Jun-17 4:40 PM View: | Oncothyreon Inc (CASC) | 12-Jun-17 | Option Exercise | 2,148 | -- | -- | 62% 3.49K to 5.64K | |
14-Mar-17 2:19 PM View: | Oncothyreon Inc (CASC) | 12-Mar-17 | Payment of Exercise | 1,164 | $4.35 | $5,063.40 | (25%) 4.66K to 3.49K | (132%) |
14-Mar-17 2:19 PM View: | Oncothyreon Inc (CASC) | 12-Mar-17 | Option Exercise | 4,656 | -- | -- | 100% 0 to 4.66K |